Tag Archives: Ocella
-
-
Yasmin, Yaz Recall Not Recommended, Stronger Warnings Are: FDA Panel
-
Yasmin, Yaz Warnings Should Be Added: FDA Staff
-
Yasmin, Yaz Blood Clot Risk 1.5 to 3 Times Higher Than Other Pills: Canada
-
Generic Yaz Birth Control by Watson Approved
-
Yasmin Birth Control Pulmonary Embolism Lawsuit Filed in Canada
-
Judge Blocks Confidential Yaz Litigation Files from Going to FDA
-
Evidence Mounts About Risk of Yaz Birth Control Side Effects
-
FDA Study Suggests Yasmin, Yaz Blood Clot Risk is 75% Higher
-
Blood Clots Risks Doubled with Yaz, Other Newer Birth Control Pills: Study